Compare MATV & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MATV | CGC |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Paper | Pharmaceuticals and Biotechnology |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.9M | 401.0M |
| IPO Year | 1996 | 2023 |
| Metric | MATV | CGC |
|---|---|---|
| Price | $12.47 | $0.98 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 453.3K | ★ 2.0M |
| Earning Date | 05-06-2026 | 05-29-2026 |
| Dividend Yield | ★ 4.24% | N/A |
| EPS Growth | N/A | ★ 84.17 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | $2.97 | $8.27 |
| Revenue Next Year | $4.20 | $15.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.07 | $0.84 |
| 52 Week High | $15.48 | $2.38 |
| Indicator | MATV | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 84.62 | 48.26 |
| Support Level | $7.58 | $0.91 |
| Resistance Level | $13.37 | $1.23 |
| Average True Range (ATR) | 0.46 | 0.04 |
| MACD | 0.29 | 0.01 |
| Stochastic Oscillator | 95.97 | 71.43 |
Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments, namely Filtration & advanced Materials, focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging, and healthcare solutions.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.